Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT06592495
PHASE1
Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315
Sponsor: Daewoong Pharmaceutical Co. LTD.
View on ClinicalTrials.gov
Summary
This study aims to evaluate the safety and pharmacokinetic characteristics after administration of DWJ1589 and DWC202315 in healty adult volunteers.
Official title: Bioepuivalence Study for the Safety and the Pharmacokinetics of DWJ1589 and DWC202315 in Healthy Adult Volunteers Under Fasting Conditions
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
52
Start Date
2024-10
Completion Date
2025-10
Last Updated
2024-09-23
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
Period 1
DWJ1589 or DWC202315
DRUG
Period 2
DWJ1589 or DWC202315
DRUG
Period 3
DWJ1589 or DWC202315
DRUG
Period 4
DWJ1589 or DWC202315